Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

Revenue Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual revenue in 2023 was 33.49 Million USD , up 579.21% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly revenue in 2024 Q1 was 251 Thousand USD , down -89.32% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a annual revenue of 4.93 Million USD in annual revenue 2022, up 146.3% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a annual revenue of 2 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly revenue of 251 Thousand USD for 2024 Q1, down -89.32% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly revenue of 33.49 Million USD for 2023 FY, up 579.21% from previous quarter.

Annual Revenue Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual Revenue of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Year Revenue Revenue Growth
2023 33.49 Million USD 579.21%
2022 4.93 Million USD 146.3%
2021 2 Million USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Revenue Revenue Difference